Jeevan Scientific Technology informs about completion of USFDA audit

24 Jan 2020 Evaluate

Jeevan Scientific Technology has informed that USFDA conducted an un-announced audit of its Bioanalytical facility in Hyderabad. The purpose of this audit was to review the BA/BE studies conducted at its facilities. The auditors started the review on 20th January, 2020 and completed on 24th January, 2020 Audit concluded with ‘No Observations’ and Auditors are pleased with company procedures. This Audit is specifically to access and approve the bioequivalence studies conducted by JSTL for Pharmaceutical companies across the globe.

The above information is a part of company’s filings submitted to BSE.

Jeevan Scientific Share Price

69.50 0.00 (0.00%)
06-Mar-2026 10:11 View Price Chart
Peers
Company Name CMP
TCS 2605.80
Infosys 1318.40
HCL Tech. 1368.65
Wipro 198.40
Tech Mahindra 1345.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×